nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—BCHE—epilepsy syndrome	0.439	0.685	CbGaD
Drospirenone—PTGS2—epilepsy syndrome	0.202	0.315	CbGaD
Drospirenone—NR3C2—hindbrain—epilepsy syndrome	0.00285	0.0741	CbGeAlD
Drospirenone—PGR—hindbrain—epilepsy syndrome	0.00265	0.0688	CbGeAlD
Drospirenone—Thrombosis—Midazolam—epilepsy syndrome	0.00231	0.0111	CcSEcCtD
Drospirenone—Embolism—Carbamazepine—epilepsy syndrome	0.00202	0.00971	CcSEcCtD
Drospirenone—Loss of libido—Gabapentin—epilepsy syndrome	0.00178	0.00859	CcSEcCtD
Drospirenone—Thrombosis—Lamotrigine—epilepsy syndrome	0.00177	0.00851	CcSEcCtD
Drospirenone—NR3C2—brainstem—epilepsy syndrome	0.00164	0.0424	CbGeAlD
Drospirenone—Depression—Primidone—epilepsy syndrome	0.00162	0.00778	CcSEcCtD
Drospirenone—Affect lability—Phenobarbital—epilepsy syndrome	0.00161	0.00776	CcSEcCtD
Drospirenone—NR3C2—forebrain—epilepsy syndrome	0.00158	0.041	CbGeAlD
Drospirenone—Breast pain—Clonazepam—epilepsy syndrome	0.00156	0.00753	CcSEcCtD
Drospirenone—Mood swings—Phenobarbital—epilepsy syndrome	0.00155	0.00747	CcSEcCtD
Drospirenone—Loss of libido—Topiramate—epilepsy syndrome	0.0015	0.00723	CcSEcCtD
Drospirenone—Affect lability—Lacosamide—epilepsy syndrome	0.00149	0.00715	CcSEcCtD
Drospirenone—Breast disorder—Rufinamide—epilepsy syndrome	0.00145	0.00699	CcSEcCtD
Drospirenone—NR3C2—telencephalon—epilepsy syndrome	0.00145	0.0377	CbGeAlD
Drospirenone—Breast pain—Lamotrigine—epilepsy syndrome	0.00143	0.0069	CcSEcCtD
Drospirenone—Mood swings—Lacosamide—epilepsy syndrome	0.00143	0.00688	CcSEcCtD
Drospirenone—Haemoglobin—Trimethadione—epilepsy syndrome	0.00129	0.00619	CcSEcCtD
Drospirenone—Haemorrhage—Trimethadione—epilepsy syndrome	0.00128	0.00616	CcSEcCtD
Drospirenone—Mental disorder—Primidone—epilepsy syndrome	0.00127	0.00613	CcSEcCtD
Drospirenone—Thrombosis—Pregabalin—epilepsy syndrome	0.00127	0.00611	CcSEcCtD
Drospirenone—Erythema multiforme—Trimethadione—epilepsy syndrome	0.00121	0.00582	CcSEcCtD
Drospirenone—Affect lability—Propofol—epilepsy syndrome	0.00119	0.00575	CcSEcCtD
Drospirenone—AR—forebrain—epilepsy syndrome	0.00117	0.0303	CbGeAlD
Drospirenone—Affect lability—Midazolam—epilepsy syndrome	0.00117	0.00562	CcSEcCtD
Drospirenone—Depression—Lacosamide—epilepsy syndrome	0.00116	0.00558	CcSEcCtD
Drospirenone—Affect lability—Levetiracetam—epilepsy syndrome	0.00115	0.00555	CcSEcCtD
Drospirenone—Mood swings—Propofol—epilepsy syndrome	0.00115	0.00553	CcSEcCtD
Drospirenone—NR3C2—medulla oblongata—epilepsy syndrome	0.00114	0.0296	CbGeAlD
Drospirenone—Depression—Clobazam—epilepsy syndrome	0.00113	0.00542	CcSEcCtD
Drospirenone—Mood swings—Midazolam—epilepsy syndrome	0.00112	0.00541	CcSEcCtD
Drospirenone—Affect lability—Fosphenytoin—epilepsy syndrome	0.00111	0.00536	CcSEcCtD
Drospirenone—Migraine—Fosphenytoin—epilepsy syndrome	0.00111	0.00536	CcSEcCtD
Drospirenone—Mood swings—Levetiracetam—epilepsy syndrome	0.00111	0.00534	CcSEcCtD
Drospirenone—Affect lability—Vigabatrin—epilepsy syndrome	0.00109	0.00522	CcSEcCtD
Drospirenone—Embolism—Topiramate—epilepsy syndrome	0.00108	0.0052	CcSEcCtD
Drospirenone—AR—telencephalon—epilepsy syndrome	0.00107	0.0279	CbGeAlD
Drospirenone—Mood swings—Fosphenytoin—epilepsy syndrome	0.00107	0.00516	CcSEcCtD
Drospirenone—Erythema multiforme—Phenobarbital—epilepsy syndrome	0.00107	0.00516	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Primidone—epilepsy syndrome	0.00107	0.00515	CcSEcCtD
Drospirenone—Affect lability—Diazepam—epilepsy syndrome	0.00107	0.00514	CcSEcCtD
Drospirenone—Cerebrovascular accident—Zonisamide—epilepsy syndrome	0.00105	0.00505	CcSEcCtD
Drospirenone—Mood swings—Vigabatrin—epilepsy syndrome	0.00104	0.00503	CcSEcCtD
Drospirenone—NR3C2—midbrain—epilepsy syndrome	0.00104	0.0271	CbGeAlD
Drospirenone—Migraine—Felbamate—epilepsy syndrome	0.00103	0.00498	CcSEcCtD
Drospirenone—Affect lability—Felbamate—epilepsy syndrome	0.00103	0.00498	CcSEcCtD
Drospirenone—Breast pain—Pregabalin—epilepsy syndrome	0.00103	0.00496	CcSEcCtD
Drospirenone—Mood swings—Diazepam—epilepsy syndrome	0.00103	0.00495	CcSEcCtD
Drospirenone—NR3C2—spinal cord—epilepsy syndrome	0.00102	0.0264	CbGeAlD
Drospirenone—Nervous system disorder—Primidone—epilepsy syndrome	0.00101	0.00488	CcSEcCtD
Drospirenone—Affect lability—Zonisamide—epilepsy syndrome	0.00101	0.00487	CcSEcCtD
Drospirenone—Skin disorder—Primidone—epilepsy syndrome	0.001	0.00483	CcSEcCtD
Drospirenone—Breast disorder—Vigabatrin—epilepsy syndrome	0.000996	0.0048	CcSEcCtD
Drospirenone—Mood swings—Felbamate—epilepsy syndrome	0.000995	0.00479	CcSEcCtD
Drospirenone—Erythema multiforme—Lacosamide—epilepsy syndrome	0.000987	0.00475	CcSEcCtD
Drospirenone—BCHE—brainstem—epilepsy syndrome	0.000985	0.0256	CbGeAlD
Drospirenone—Affect lability—Clonazepam—epilepsy syndrome	0.000975	0.0047	CcSEcCtD
Drospirenone—Migraine—Clonazepam—epilepsy syndrome	0.000975	0.0047	CcSEcCtD
Drospirenone—Mental disorder—Rufinamide—epilepsy syndrome	0.000974	0.00469	CcSEcCtD
Drospirenone—Mood swings—Zonisamide—epilepsy syndrome	0.000974	0.00469	CcSEcCtD
Drospirenone—Migraine—Phenytoin—epilepsy syndrome	0.000969	0.00466	CcSEcCtD
Drospirenone—Affect lability—Phenytoin—epilepsy syndrome	0.000969	0.00466	CcSEcCtD
Drospirenone—Migraine—Oxcarbazepine—epilepsy syndrome	0.000964	0.00464	CcSEcCtD
Drospirenone—Affect lability—Oxcarbazepine—epilepsy syndrome	0.000964	0.00464	CcSEcCtD
Drospirenone—Erythema multiforme—Clobazam—epilepsy syndrome	0.000958	0.00461	CcSEcCtD
Drospirenone—BCHE—forebrain—epilepsy syndrome	0.000951	0.0247	CbGeAlD
Drospirenone—Breast pain—Gabapentin—epilepsy syndrome	0.000944	0.00455	CcSEcCtD
Drospirenone—Mood swings—Clonazepam—epilepsy syndrome	0.000939	0.00452	CcSEcCtD
Drospirenone—Mood swings—Phenytoin—epilepsy syndrome	0.000932	0.00449	CcSEcCtD
Drospirenone—Depression—Propofol—epilepsy syndrome	0.000932	0.00449	CcSEcCtD
Drospirenone—Mood swings—Oxcarbazepine—epilepsy syndrome	0.000928	0.00447	CcSEcCtD
Drospirenone—Cerebrovascular accident—Lamotrigine—epilepsy syndrome	0.000927	0.00446	CcSEcCtD
Drospirenone—Acute coronary syndrome—Propofol—epilepsy syndrome	0.000921	0.00444	CcSEcCtD
Drospirenone—Myocardial infarction—Propofol—epilepsy syndrome	0.000916	0.00441	CcSEcCtD
Drospirenone—Mental disorder—Lacosamide—epilepsy syndrome	0.000915	0.0044	CcSEcCtD
Drospirenone—Depression—Midazolam—epilepsy syndrome	0.000912	0.00439	CcSEcCtD
Drospirenone—NR3C2—head—epilepsy syndrome	0.000904	0.0235	CbGeAlD
Drospirenone—Depression—Levetiracetam—epilepsy syndrome	0.0009	0.00434	CcSEcCtD
Drospirenone—Breast disorder—Clonazepam—epilepsy syndrome	0.000895	0.00431	CcSEcCtD
Drospirenone—Migraine—Lamotrigine—epilepsy syndrome	0.000894	0.0043	CcSEcCtD
Drospirenone—Affect lability—Lamotrigine—epilepsy syndrome	0.000894	0.0043	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Primidone—epilepsy syndrome	0.000892	0.00429	CcSEcCtD
Drospirenone—Breast disorder—Phenytoin—epilepsy syndrome	0.000889	0.00428	CcSEcCtD
Drospirenone—Mental disorder—Clobazam—epilepsy syndrome	0.000888	0.00427	CcSEcCtD
Drospirenone—BCHE—telencephalon—epilepsy syndrome	0.000874	0.0227	CbGeAlD
Drospirenone—Mood swings—Lamotrigine—epilepsy syndrome	0.00086	0.00414	CcSEcCtD
Drospirenone—NR3C2—nervous system—epilepsy syndrome	0.000857	0.0222	CbGeAlD
Drospirenone—Erythema multiforme—Acetazolamide—epilepsy syndrome	0.000854	0.00411	CcSEcCtD
Drospirenone—Depression—Vigabatrin—epilepsy syndrome	0.000847	0.00408	CcSEcCtD
Drospirenone—Haemoglobin—Propofol—epilepsy syndrome	0.000843	0.00406	CcSEcCtD
Drospirenone—PGR—head—epilepsy syndrome	0.00084	0.0218	CbGeAlD
Drospirenone—Haemorrhage—Propofol—epilepsy syndrome	0.000839	0.00404	CcSEcCtD
Drospirenone—Depression—Diazepam—epilepsy syndrome	0.000834	0.00402	CcSEcCtD
Drospirenone—NR3C2—central nervous system—epilepsy syndrome	0.000825	0.0214	CbGeAlD
Drospirenone—Acute coronary syndrome—Diazepam—epilepsy syndrome	0.000824	0.00397	CcSEcCtD
Drospirenone—Myocardial infarction—Diazepam—epilepsy syndrome	0.00082	0.00395	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Rufinamide—epilepsy syndrome	0.000819	0.00394	CcSEcCtD
Drospirenone—Depression—Felbamate—epilepsy syndrome	0.000807	0.00389	CcSEcCtD
Drospirenone—NR3C2—cerebellum—epilepsy syndrome	0.000806	0.0209	CbGeAlD
Drospirenone—PGR—nervous system—epilepsy syndrome	0.000796	0.0207	CbGeAlD
Drospirenone—Breast pain—Topiramate—epilepsy syndrome	0.000795	0.00383	CcSEcCtD
Drospirenone—Depression—Zonisamide—epilepsy syndrome	0.00079	0.0038	CcSEcCtD
Drospirenone—Nervous system disorder—Rufinamide—epilepsy syndrome	0.000775	0.00373	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Lacosamide—epilepsy syndrome	0.000769	0.0037	CcSEcCtD
Drospirenone—Skin disorder—Rufinamide—epilepsy syndrome	0.000767	0.0037	CcSEcCtD
Drospirenone—PGR—central nervous system—epilepsy syndrome	0.000767	0.0199	CbGeAlD
Drospirenone—Erythema multiforme—Levetiracetam—epilepsy syndrome	0.000766	0.00369	CcSEcCtD
Drospirenone—Depression—Clonazepam—epilepsy syndrome	0.000761	0.00367	CcSEcCtD
Drospirenone—AR—spinal cord—epilepsy syndrome	0.000753	0.0195	CbGeAlD
Drospirenone—PGR—cerebellum—epilepsy syndrome	0.000749	0.0195	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Clobazam—epilepsy syndrome	0.000746	0.00359	CcSEcCtD
Drospirenone—PTGS2—forebrain—epilepsy syndrome	0.000733	0.019	CbGeAlD
Drospirenone—Haemoglobin—Felbamate—epilepsy syndrome	0.00073	0.00352	CcSEcCtD
Drospirenone—Nervous system disorder—Lacosamide—epilepsy syndrome	0.000728	0.0035	CcSEcCtD
Drospirenone—Haemorrhage—Felbamate—epilepsy syndrome	0.000727	0.0035	CcSEcCtD
Drospirenone—Depression—Carbamazepine—epilepsy syndrome	0.000722	0.00348	CcSEcCtD
Drospirenone—Erythema multiforme—Vigabatrin—epilepsy syndrome	0.000721	0.00347	CcSEcCtD
Drospirenone—Skin disorder—Lacosamide—epilepsy syndrome	0.000721	0.00347	CcSEcCtD
Drospirenone—Mental disorder—Midazolam—epilepsy syndrome	0.000719	0.00346	CcSEcCtD
Drospirenone—Affect lability—Valproic Acid—epilepsy syndrome	0.00071	0.00342	CcSEcCtD
Drospirenone—Mental disorder—Levetiracetam—epilepsy syndrome	0.00071	0.00342	CcSEcCtD
Drospirenone—Nervous system disorder—Clobazam—epilepsy syndrome	0.000706	0.0034	CcSEcCtD
Drospirenone—Skin disorder—Clobazam—epilepsy syndrome	0.000699	0.00337	CcSEcCtD
Drospirenone—Depression—Lamotrigine—epilepsy syndrome	0.000698	0.00336	CcSEcCtD
Drospirenone—Acute coronary syndrome—Lamotrigine—epilepsy syndrome	0.00069	0.00332	CcSEcCtD
Drospirenone—Haemoglobin—Clonazepam—epilepsy syndrome	0.000689	0.00332	CcSEcCtD
Drospirenone—Erythema multiforme—Felbamate—epilepsy syndrome	0.000687	0.00331	CcSEcCtD
Drospirenone—BCHE—medulla oblongata—epilepsy syndrome	0.000687	0.0178	CbGeAlD
Drospirenone—Myocardial infarction—Lamotrigine—epilepsy syndrome	0.000686	0.0033	CcSEcCtD
Drospirenone—Haemorrhage—Clonazepam—epilepsy syndrome	0.000686	0.0033	CcSEcCtD
Drospirenone—Haemoglobin—Phenytoin—epilepsy syndrome	0.000684	0.0033	CcSEcCtD
Drospirenone—Mood swings—Valproic Acid—epilepsy syndrome	0.000684	0.00329	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Rufinamide—epilepsy syndrome	0.000682	0.00328	CcSEcCtD
Drospirenone—Angiopathy—Diazepam—epilepsy syndrome	0.000681	0.00328	CcSEcCtD
Drospirenone—Haemorrhage—Phenytoin—epilepsy syndrome	0.000681	0.00328	CcSEcCtD
Drospirenone—PTGS2—telencephalon—epilepsy syndrome	0.000674	0.0175	CbGeAlD
Drospirenone—Erythema multiforme—Zonisamide—epilepsy syndrome	0.000673	0.00324	CcSEcCtD
Drospirenone—AR—head—epilepsy syndrome	0.000669	0.0174	CbGeAlD
Drospirenone—Mental disorder—Vigabatrin—epilepsy syndrome	0.000668	0.00322	CcSEcCtD
Drospirenone—Cerebrovascular accident—Pregabalin—epilepsy syndrome	0.000666	0.0032	CcSEcCtD
Drospirenone—Mental disorder—Diazepam—epilepsy syndrome	0.000658	0.00317	CcSEcCtD
Drospirenone—NR3C2—brain—epilepsy syndrome	0.000655	0.017	CbGeAlD
Drospirenone—Breast disorder—Valproic Acid—epilepsy syndrome	0.000652	0.00314	CcSEcCtD
Drospirenone—Erythema multiforme—Phenytoin—epilepsy syndrome	0.000644	0.0031	CcSEcCtD
Drospirenone—Affect lability—Pregabalin—epilepsy syndrome	0.000642	0.00309	CcSEcCtD
Drospirenone—Migraine—Pregabalin—epilepsy syndrome	0.000642	0.00309	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Lacosamide—epilepsy syndrome	0.000641	0.00308	CcSEcCtD
Drospirenone—Erythema multiforme—Oxcarbazepine—epilepsy syndrome	0.00064	0.00308	CcSEcCtD
Drospirenone—Nausea—Amobarbital—epilepsy syndrome	0.000637	0.00307	CcSEcCtD
Drospirenone—AR—nervous system—epilepsy syndrome	0.000634	0.0165	CbGeAlD
Drospirenone—Haemoglobin—Lamotrigine—epilepsy syndrome	0.000631	0.00304	CcSEcCtD
Drospirenone—Haemorrhage—Lamotrigine—epilepsy syndrome	0.000628	0.00302	CcSEcCtD
Drospirenone—BCHE—midbrain—epilepsy syndrome	0.000628	0.0163	CbGeAlD
Drospirenone—Mental disorder—Zonisamide—epilepsy syndrome	0.000623	0.003	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Clobazam—epilepsy syndrome	0.000622	0.00299	CcSEcCtD
Drospirenone—Mood swings—Pregabalin—epilepsy syndrome	0.000618	0.00298	CcSEcCtD
Drospirenone—Erythema multiforme—Carbamazepine—epilepsy syndrome	0.000615	0.00296	CcSEcCtD
Drospirenone—Angiopathy—Oxcarbazepine—epilepsy syndrome	0.000615	0.00296	CcSEcCtD
Drospirenone—Nausea—Primidone—epilepsy syndrome	0.000614	0.00295	CcSEcCtD
Drospirenone—BCHE—spinal cord—epilepsy syndrome	0.000613	0.0159	CbGeAlD
Drospirenone—AR—central nervous system—epilepsy syndrome	0.000611	0.0159	CbGeAlD
Drospirenone—Cerebrovascular accident—Gabapentin—epilepsy syndrome	0.00061	0.00294	CcSEcCtD
Drospirenone—PGR—brain—epilepsy syndrome	0.000609	0.0158	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Midazolam—epilepsy syndrome	0.000604	0.00291	CcSEcCtD
Drospirenone—Spironolactone—SLCO1A2—epilepsy syndrome	0.000604	0.0974	CrCbGaD
Drospirenone—Mental disorder—Clonazepam—epilepsy syndrome	0.000601	0.00289	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Levetiracetam—epilepsy syndrome	0.000597	0.00287	CcSEcCtD
Drospirenone—Erythema multiforme—Lamotrigine—epilepsy syndrome	0.000594	0.00286	CcSEcCtD
Drospirenone—Mental disorder—Oxcarbazepine—epilepsy syndrome	0.000593	0.00286	CcSEcCtD
Drospirenone—Angiopathy—Carbamazepine—epilepsy syndrome	0.00059	0.00284	CcSEcCtD
Drospirenone—Breast disorder—Pregabalin—epilepsy syndrome	0.000589	0.00284	CcSEcCtD
Drospirenone—Migraine—Gabapentin—epilepsy syndrome	0.000589	0.00283	CcSEcCtD
Drospirenone—Affect lability—Gabapentin—epilepsy syndrome	0.000589	0.00283	CcSEcCtD
Drospirenone—Nervous system disorder—Midazolam—epilepsy syndrome	0.000572	0.00275	CcSEcCtD
Drospirenone—Angiopathy—Lamotrigine—epilepsy syndrome	0.00057	0.00274	CcSEcCtD
Drospirenone—Mental disorder—Carbamazepine—epilepsy syndrome	0.000569	0.00274	CcSEcCtD
Drospirenone—Mood swings—Gabapentin—epilepsy syndrome	0.000567	0.00273	CcSEcCtD
Drospirenone—Skin disorder—Midazolam—epilepsy syndrome	0.000566	0.00273	CcSEcCtD
Drospirenone—Nervous system disorder—Levetiracetam—epilepsy syndrome	0.000565	0.00272	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Vigabatrin—epilepsy syndrome	0.000561	0.0027	CcSEcCtD
Drospirenone—Skin disorder—Levetiracetam—epilepsy syndrome	0.000559	0.00269	CcSEcCtD
Drospirenone—Depression—Valproic Acid—epilepsy syndrome	0.000554	0.00267	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.000554	0.00267	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Diazepam—epilepsy syndrome	0.000553	0.00266	CcSEcCtD
Drospirenone—Mental disorder—Lamotrigine—epilepsy syndrome	0.00055	0.00265	CcSEcCtD
Drospirenone—BCHE—head—epilepsy syndrome	0.000544	0.0141	CbGeAlD
Drospirenone—Breast disorder—Gabapentin—epilepsy syndrome	0.000541	0.0026	CcSEcCtD
Drospirenone—Nausea—Trimethadione—epilepsy syndrome	0.00054	0.0026	CcSEcCtD
Drospirenone—Methyltestosterone—SLCO1A2—epilepsy syndrome	0.000533	0.0859	CrCbGaD
Drospirenone—Nervous system disorder—Vigabatrin—epilepsy syndrome	0.000531	0.00256	CcSEcCtD
Drospirenone—PTGS2—medulla oblongata—epilepsy syndrome	0.000529	0.0137	CbGeAlD
Drospirenone—Skin disorder—Vigabatrin—epilepsy syndrome	0.000526	0.00253	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Zonisamide—epilepsy syndrome	0.000524	0.00252	CcSEcCtD
Drospirenone—Nervous system disorder—Diazepam—epilepsy syndrome	0.000523	0.00252	CcSEcCtD
Drospirenone—Skin disorder—Diazepam—epilepsy syndrome	0.000518	0.00249	CcSEcCtD
Drospirenone—BCHE—nervous system—epilepsy syndrome	0.000516	0.0134	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Clonazepam—epilepsy syndrome	0.000505	0.00243	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.000504	0.00242	CcSEcCtD
Drospirenone—Haemoglobin—Valproic Acid—epilepsy syndrome	0.000502	0.00242	CcSEcCtD
Drospirenone—Depression—Pregabalin—epilepsy syndrome	0.000501	0.00241	CcSEcCtD
Drospirenone—Haemorrhage—Valproic Acid—epilepsy syndrome	0.000499	0.0024	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Oxcarbazepine—epilepsy syndrome	0.000499	0.0024	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.000497	0.00239	CcSEcCtD
Drospirenone—BCHE—central nervous system—epilepsy syndrome	0.000497	0.0129	CbGeAlD
Drospirenone—Nervous system disorder—Zonisamide—epilepsy syndrome	0.000496	0.00239	CcSEcCtD
Drospirenone—Acute coronary syndrome—Pregabalin—epilepsy syndrome	0.000496	0.00239	CcSEcCtD
Drospirenone—Migraine—Topiramate—epilepsy syndrome	0.000495	0.00238	CcSEcCtD
Drospirenone—Affect lability—Topiramate—epilepsy syndrome	0.000495	0.00238	CcSEcCtD
Drospirenone—Myocardial infarction—Pregabalin—epilepsy syndrome	0.000493	0.00237	CcSEcCtD
Drospirenone—Skin disorder—Zonisamide—epilepsy syndrome	0.000491	0.00236	CcSEcCtD
Drospirenone—BCHE—cerebellum—epilepsy syndrome	0.000486	0.0126	CbGeAlD
Drospirenone—AR—brain—epilepsy syndrome	0.000485	0.0126	CbGeAlD
Drospirenone—PTGS2—midbrain—epilepsy syndrome	0.000484	0.0126	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Carbamazepine—epilepsy syndrome	0.000478	0.0023	CcSEcCtD
Drospirenone—Nausea—Phenobarbital—epilepsy syndrome	0.000478	0.0023	CcSEcCtD
Drospirenone—Nervous system disorder—Clonazepam—epilepsy syndrome	0.000478	0.0023	CcSEcCtD
Drospirenone—Mood swings—Topiramate—epilepsy syndrome	0.000477	0.0023	CcSEcCtD
Drospirenone—Nervous system disorder—Phenytoin—epilepsy syndrome	0.000474	0.00228	CcSEcCtD
Drospirenone—Skin disorder—Clonazepam—epilepsy syndrome	0.000473	0.00228	CcSEcCtD
Drospirenone—Erythema multiforme—Valproic Acid—epilepsy syndrome	0.000472	0.00227	CcSEcCtD
Drospirenone—PTGS2—spinal cord—epilepsy syndrome	0.000472	0.0123	CbGeAlD
Drospirenone—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	0.000472	0.00227	CcSEcCtD
Drospirenone—Nausea—Rufinamide—epilepsy syndrome	0.000469	0.00226	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000468	0.00225	CcSEcCtD
Drospirenone—Skin disorder—Oxcarbazepine—epilepsy syndrome	0.000467	0.00225	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000461	0.00222	CcSEcCtD
Drospirenone—Depression—Gabapentin—epilepsy syndrome	0.00046	0.00221	CcSEcCtD
Drospirenone—Breast disorder—Topiramate—epilepsy syndrome	0.000455	0.00219	CcSEcCtD
Drospirenone—Acute coronary syndrome—Gabapentin—epilepsy syndrome	0.000454	0.00219	CcSEcCtD
Drospirenone—Haemoglobin—Pregabalin—epilepsy syndrome	0.000454	0.00218	CcSEcCtD
Drospirenone—Angiopathy—Valproic Acid—epilepsy syndrome	0.000453	0.00218	CcSEcCtD
Drospirenone—Nervous system disorder—Carbamazepine—epilepsy syndrome	0.000453	0.00218	CcSEcCtD
Drospirenone—Myocardial infarction—Gabapentin—epilepsy syndrome	0.000452	0.00218	CcSEcCtD
Drospirenone—Haemorrhage—Pregabalin—epilepsy syndrome	0.000451	0.00217	CcSEcCtD
Drospirenone—Skin disorder—Carbamazepine—epilepsy syndrome	0.000449	0.00216	CcSEcCtD
Drospirenone—Nausea—Lacosamide—epilepsy syndrome	0.000441	0.00212	CcSEcCtD
Drospirenone—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000438	0.00211	CcSEcCtD
Drospirenone—Mental disorder—Valproic Acid—epilepsy syndrome	0.000437	0.00211	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000436	0.0021	CcSEcCtD
Drospirenone—Nausea—Clobazam—epilepsy syndrome	0.000428	0.00206	CcSEcCtD
Drospirenone—Erythema multiforme—Pregabalin—epilepsy syndrome	0.000427	0.00205	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.00042	0.00202	CcSEcCtD
Drospirenone—PTGS2—head—epilepsy syndrome	0.000419	0.0109	CbGeAlD
Drospirenone—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000418	0.00201	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000415	0.002	CcSEcCtD
Drospirenone—Haemorrhage—Gabapentin—epilepsy syndrome	0.000414	0.00199	CcSEcCtD
Drospirenone—Angiopathy—Pregabalin—epilepsy syndrome	0.000409	0.00197	CcSEcCtD
Drospirenone—Hydrocortisone—SLCO1A2—epilepsy syndrome	0.000401	0.0647	CrCbGaD
Drospirenone—Medrysone—NR3C1—epilepsy syndrome	0.0004	0.0646	CrCbGaD
Drospirenone—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000399	0.00192	CcSEcCtD
Drospirenone—PTGS2—nervous system—epilepsy syndrome	0.000398	0.0103	CbGeAlD
Drospirenone—Mental disorder—Pregabalin—epilepsy syndrome	0.000395	0.0019	CcSEcCtD
Drospirenone—BCHE—brain—epilepsy syndrome	0.000395	0.0102	CbGeAlD
Drospirenone—Erythema multiforme—Gabapentin—epilepsy syndrome	0.000391	0.00188	CcSEcCtD
Drospirenone—Depression—Topiramate—epilepsy syndrome	0.000387	0.00186	CcSEcCtD
Drospirenone—Flurandrenolide—NR3C1—epilepsy syndrome	0.000386	0.0622	CrCbGaD
Drospirenone—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000385	0.00186	CcSEcCtD
Drospirenone—PTGS2—central nervous system—epilepsy syndrome	0.000383	0.00994	CbGeAlD
Drospirenone—Nausea—Acetazolamide—epilepsy syndrome	0.000381	0.00184	CcSEcCtD
Drospirenone—PTGS2—cerebellum—epilepsy syndrome	0.000374	0.00972	CbGeAlD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000367	0.00177	CcSEcCtD
Drospirenone—Cortisone acetate—NR3C1—epilepsy syndrome	0.000367	0.0593	CrCbGaD
Drospirenone—Mental disorder—Gabapentin—epilepsy syndrome	0.000363	0.00175	CcSEcCtD
Drospirenone—Megestrol acetate—NR3C1—epilepsy syndrome	0.000354	0.0571	CrCbGaD
Drospirenone—Nausea—Propofol—epilepsy syndrome	0.000354	0.0017	CcSEcCtD
Drospirenone—Haemoglobin—Topiramate—epilepsy syndrome	0.00035	0.00168	CcSEcCtD
Drospirenone—Haemorrhage—Topiramate—epilepsy syndrome	0.000348	0.00168	CcSEcCtD
Drospirenone—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000348	0.00167	CcSEcCtD
Drospirenone—Nausea—Midazolam—epilepsy syndrome	0.000346	0.00167	CcSEcCtD
Drospirenone—Skin disorder—Valproic Acid—epilepsy syndrome	0.000344	0.00166	CcSEcCtD
Drospirenone—Nausea—Levetiracetam—epilepsy syndrome	0.000342	0.00165	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000332	0.0016	CcSEcCtD
Drospirenone—Nausea—Fosphenytoin—epilepsy syndrome	0.00033	0.00159	CcSEcCtD
Drospirenone—Erythema multiforme—Topiramate—epilepsy syndrome	0.000329	0.00158	CcSEcCtD
Drospirenone—Nausea—Vigabatrin—epilepsy syndrome	0.000322	0.00155	CcSEcCtD
Drospirenone—Nausea—Diazepam—epilepsy syndrome	0.000317	0.00153	CcSEcCtD
Drospirenone—Angiopathy—Topiramate—epilepsy syndrome	0.000316	0.00152	CcSEcCtD
Drospirenone—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000314	0.00151	CcSEcCtD
Drospirenone—Skin disorder—Pregabalin—epilepsy syndrome	0.000311	0.0015	CcSEcCtD
Drospirenone—Testosterone—SLCO1A2—epilepsy syndrome	0.000309	0.0498	CrCbGaD
Drospirenone—Nausea—Felbamate—epilepsy syndrome	0.000307	0.00148	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000306	0.00147	CcSEcCtD
Drospirenone—Mental disorder—Topiramate—epilepsy syndrome	0.000305	0.00147	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000305	0.00147	CcSEcCtD
Drospirenone—PTGS2—brain—epilepsy syndrome	0.000304	0.00789	CbGeAlD
Drospirenone—Nausea—Zonisamide—epilepsy syndrome	0.0003	0.00145	CcSEcCtD
Drospirenone—Nausea—Clonazepam—epilepsy syndrome	0.000289	0.00139	CcSEcCtD
Drospirenone—Spironolactone—ABCC2—epilepsy syndrome	0.000289	0.0466	CrCbGaD
Drospirenone—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000288	0.00139	CcSEcCtD
Drospirenone—Nausea—Phenytoin—epilepsy syndrome	0.000287	0.00138	CcSEcCtD
Drospirenone—Nausea—Oxcarbazepine—epilepsy syndrome	0.000286	0.00138	CcSEcCtD
Drospirenone—Skin disorder—Gabapentin—epilepsy syndrome	0.000286	0.00137	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000277	0.00133	CcSEcCtD
Drospirenone—Nausea—Carbamazepine—epilepsy syndrome	0.000274	0.00132	CcSEcCtD
Drospirenone—Testosterone—CYP11A1—epilepsy syndrome	0.000269	0.0434	CrCbGaD
Drospirenone—Nausea—Lamotrigine—epilepsy syndrome	0.000265	0.00128	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000256	0.00123	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000254	0.00122	CcSEcCtD
Drospirenone—Nervous system disorder—Topiramate—epilepsy syndrome	0.000243	0.00117	CcSEcCtD
Drospirenone—Skin disorder—Topiramate—epilepsy syndrome	0.00024	0.00116	CcSEcCtD
Drospirenone—Spironolactone—NR3C1—epilepsy syndrome	0.00022	0.0355	CrCbGaD
Drospirenone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000214	0.00103	CcSEcCtD
Drospirenone—Nausea—Valproic Acid—epilepsy syndrome	0.000211	0.00101	CcSEcCtD
Drospirenone—Medroxyprogesterone Acetate—NR3C1—epilepsy syndrome	0.000206	0.0333	CrCbGaD
Drospirenone—Nausea—Pregabalin—epilepsy syndrome	0.00019	0.000917	CcSEcCtD
Drospirenone—Norethindrone—CYP2C19—epilepsy syndrome	0.000186	0.0301	CrCbGaD
Drospirenone—Nausea—Gabapentin—epilepsy syndrome	0.000175	0.000841	CcSEcCtD
Drospirenone—Megestrol acetate—ABCB1—epilepsy syndrome	0.000171	0.0276	CrCbGaD
Drospirenone—Hydrocortisone—ABCG2—epilepsy syndrome	0.00017	0.0274	CrCbGaD
Drospirenone—Nausea—Topiramate—epilepsy syndrome	0.000147	0.000707	CcSEcCtD
Drospirenone—Hydrocortisone—NR3C1—epilepsy syndrome	0.000146	0.0236	CrCbGaD
Drospirenone—Testosterone—ABCG2—epilepsy syndrome	0.000131	0.0211	CrCbGaD
Drospirenone—Progesterone—NR3C1—epilepsy syndrome	0.000119	0.0192	CrCbGaD
Drospirenone—Progesterone—CYP2C19—epilepsy syndrome	0.000109	0.0175	CrCbGaD
Drospirenone—Spironolactone—ABCB1—epilepsy syndrome	0.000106	0.0171	CrCbGaD
Drospirenone—Norethindrone—ALB—epilepsy syndrome	0.000103	0.0167	CrCbGaD
Drospirenone—Testosterone—CYP2C19—epilepsy syndrome	0.000103	0.0166	CrCbGaD
Drospirenone—Norethindrone—ABCB1—epilepsy syndrome	9.87e-05	0.0159	CrCbGaD
Drospirenone—Methyltestosterone—ALB—epilepsy syndrome	9.82e-05	0.0158	CrCbGaD
Drospirenone—Progesterone—CYP2D6—epilepsy syndrome	8.05e-05	0.013	CrCbGaD
Drospirenone—Hydrocortisone—ABCB1—epilepsy syndrome	7.06e-05	0.0114	CrCbGaD
Drospirenone—Progesterone—ABCB1—epilepsy syndrome	5.75e-05	0.00928	CrCbGaD
Drospirenone—Testosterone—ALB—epilepsy syndrome	5.7e-05	0.00919	CrCbGaD
Drospirenone—Testosterone—ABCB1—epilepsy syndrome	5.44e-05	0.00877	CrCbGaD
Drospirenone—BCHE—Metabolism—GBE1—epilepsy syndrome	5.04e-05	0.000474	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PPP1R3C—epilepsy syndrome	5.04e-05	0.000474	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—HSPB1—epilepsy syndrome	5.03e-05	0.000473	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GRM8—epilepsy syndrome	5.02e-05	0.000472	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PGF—epilepsy syndrome	5.02e-05	0.000472	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—EIF2S1—epilepsy syndrome	5.01e-05	0.000471	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—YWHAZ—epilepsy syndrome	5.01e-05	0.00047	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—ACTB—epilepsy syndrome	4.95e-05	0.000465	CbGpPWpGaD
Drospirenone—BCHE—Neuronal System—PRKCB—epilepsy syndrome	4.94e-05	0.000465	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—NR3C1—epilepsy syndrome	4.93e-05	0.000463	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—EPM2A—epilepsy syndrome	4.93e-05	0.000463	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NHLRC1—epilepsy syndrome	4.93e-05	0.000463	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PNPO—epilepsy syndrome	4.93e-05	0.000463	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GAMT—epilepsy syndrome	4.93e-05	0.000463	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PFKL—epilepsy syndrome	4.87e-05	0.000458	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GNAO1—epilepsy syndrome	4.79e-05	0.00045	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—OPRD1—epilepsy syndrome	4.79e-05	0.00045	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—NR3C1—epilepsy syndrome	4.75e-05	0.000446	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ASAH1—epilepsy syndrome	4.74e-05	0.000445	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	4.71e-05	0.000443	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	4.7e-05	0.000442	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	4.62e-05	0.000434	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—AKT1—epilepsy syndrome	4.61e-05	0.000433	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—STXBP1—epilepsy syndrome	4.61e-05	0.000433	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CHRM1—epilepsy syndrome	4.59e-05	0.000431	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PDYN—epilepsy syndrome	4.59e-05	0.000431	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR7—epilepsy syndrome	4.59e-05	0.000431	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GRM1—epilepsy syndrome	4.59e-05	0.000431	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	4.59e-05	0.000431	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	4.58e-05	0.00043	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CA4—epilepsy syndrome	4.58e-05	0.00043	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—QDPR—epilepsy syndrome	4.58e-05	0.00043	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	4.57e-05	0.000429	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NT5E—epilepsy syndrome	4.49e-05	0.000422	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALAD—epilepsy syndrome	4.49e-05	0.000422	CbGpPWpGaD
Drospirenone—PTGS2—Disease—STX1B—epilepsy syndrome	4.46e-05	0.000419	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	4.32e-05	0.000406	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GFAP—epilepsy syndrome	4.32e-05	0.000406	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GAL—epilepsy syndrome	4.32e-05	0.000406	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—COX3—epilepsy syndrome	4.31e-05	0.000405	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALDH7A1—epilepsy syndrome	4.29e-05	0.000403	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CACNA1A—epilepsy syndrome	4.29e-05	0.000403	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CHRM3—epilepsy syndrome	4.27e-05	0.000401	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GRM5—epilepsy syndrome	4.27e-05	0.000401	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CASP2—epilepsy syndrome	4.27e-05	0.000401	CbGpPWpGaD
Drospirenone—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	4.2e-05	0.000395	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—JUNB—epilepsy syndrome	4.2e-05	0.000395	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ST3GAL3—epilepsy syndrome	4.2e-05	0.000394	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GBE1—epilepsy syndrome	4.14e-05	0.000389	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CPSF4—epilepsy syndrome	4.14e-05	0.000389	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PPP1R3C—epilepsy syndrome	4.14e-05	0.000389	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ADSL—epilepsy syndrome	4.11e-05	0.000386	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	4.11e-05	0.000386	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CX3CR1—epilepsy syndrome	4.09e-05	0.000385	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	4.08e-05	0.000383	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PFKL—epilepsy syndrome	4.08e-05	0.000383	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—KCNB1—epilepsy syndrome	4.08e-05	0.000383	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	4.08e-05	0.000383	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	4.08e-05	0.000383	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GLUL—epilepsy syndrome	4.03e-05	0.000379	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CHRM2—epilepsy syndrome	4.01e-05	0.000377	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—BDKRB1—epilepsy syndrome	4.01e-05	0.000377	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CX3CL1—epilepsy syndrome	4.01e-05	0.000377	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.99e-05	0.000375	CbGpPWpGaD
Drospirenone—AR—Gene Expression—EIF2S1—epilepsy syndrome	3.97e-05	0.000373	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.96e-05	0.000373	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CACNA1D—epilepsy syndrome	3.96e-05	0.000372	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	3.93e-05	0.000369	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GABBR1—epilepsy syndrome	3.9e-05	0.000367	CbGpPWpGaD
Drospirenone—AR—Gene Expression—HSPB1—epilepsy syndrome	3.83e-05	0.00036	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HRH3—epilepsy syndrome	3.74e-05	0.000352	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ATIC—epilepsy syndrome	3.73e-05	0.000351	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—UPB1—epilepsy syndrome	3.73e-05	0.000351	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NEU1—epilepsy syndrome	3.73e-05	0.000351	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	3.71e-05	0.000349	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—PLAUR—epilepsy syndrome	3.7e-05	0.000348	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TXNRD1—epilepsy syndrome	3.7e-05	0.000348	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—OPRM1—epilepsy syndrome	3.68e-05	0.000346	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	3.59e-05	0.000338	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AQP1—epilepsy syndrome	3.59e-05	0.000338	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	3.53e-05	0.000332	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	3.52e-05	0.000331	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR3—epilepsy syndrome	3.48e-05	0.000327	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GBE1—epilepsy syndrome	3.47e-05	0.000326	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	3.47e-05	0.000326	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.45e-05	0.000324	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ST3GAL3—epilepsy syndrome	3.45e-05	0.000324	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.39e-05	0.000319	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NPY—epilepsy syndrome	3.39e-05	0.000319	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ATP2A2—epilepsy syndrome	3.39e-05	0.000319	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SIRT1—epilepsy syndrome	3.38e-05	0.000318	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—VDR—epilepsy syndrome	3.33e-05	0.000313	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	3.32e-05	0.000312	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CRH—epilepsy syndrome	3.27e-05	0.000307	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL3—epilepsy syndrome	3.27e-05	0.000307	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—OXT—epilepsy syndrome	3.27e-05	0.000307	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL2—epilepsy syndrome	3.27e-05	0.000307	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HSPB1—epilepsy syndrome	3.27e-05	0.000307	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ASAH1—epilepsy syndrome	3.26e-05	0.000307	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CHRM3—epilepsy syndrome	3.25e-05	0.000305	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—KCNJ11—epilepsy syndrome	3.25e-05	0.000305	CbGpPWpGaD
Drospirenone—AR—Gene Expression—JUNB—epilepsy syndrome	3.2e-05	0.000301	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—STXBP1—epilepsy syndrome	3.17e-05	0.000298	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—H2AFX—epilepsy syndrome	3.16e-05	0.000297	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	3.11e-05	0.000292	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NT5E—epilepsy syndrome	3.09e-05	0.000291	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALAD—epilepsy syndrome	3.09e-05	0.000291	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—YWHAZ—epilepsy syndrome	3.05e-05	0.000286	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PTK2B—epilepsy syndrome	3.04e-05	0.000286	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TSC1—epilepsy syndrome	3.04e-05	0.000286	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.03e-05	0.000284	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	3.02e-05	0.000284	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NR3C1—epilepsy syndrome	3e-05	0.000282	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.96e-05	0.000279	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NTRK2—epilepsy syndrome	2.96e-05	0.000278	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR2—epilepsy syndrome	2.96e-05	0.000278	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SST—epilepsy syndrome	2.96e-05	0.000278	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	2.95e-05	0.000277	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	2.95e-05	0.000277	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—DUSP6—epilepsy syndrome	2.93e-05	0.000276	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.93e-05	0.000275	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADRA2A—epilepsy syndrome	2.9e-05	0.000272	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	2.89e-05	0.000271	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PLAT—epilepsy syndrome	2.88e-05	0.000271	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ADSL—epilepsy syndrome	2.83e-05	0.000266	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—BDKRB2—epilepsy syndrome	2.78e-05	0.000261	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL12—epilepsy syndrome	2.78e-05	0.000261	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GLUL—epilepsy syndrome	2.77e-05	0.000261	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JUNB—epilepsy syndrome	2.73e-05	0.000257	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CNR1—epilepsy syndrome	2.73e-05	0.000257	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	2.72e-05	0.000256	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PLCB1—epilepsy syndrome	2.72e-05	0.000256	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	2.71e-05	0.000254	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR7—epilepsy syndrome	2.66e-05	0.00025	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ABCG2—epilepsy syndrome	2.65e-05	0.000249	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	2.64e-05	0.000248	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—AGT—epilepsy syndrome	2.61e-05	0.000246	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HBEGF—epilepsy syndrome	2.59e-05	0.000243	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP2C19—epilepsy syndrome	2.58e-05	0.000243	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SIRT1—epilepsy syndrome	2.58e-05	0.000242	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP11A1—epilepsy syndrome	2.56e-05	0.000241	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	2.55e-05	0.000239	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.55e-05	0.000239	CbGpPWpGaD
Drospirenone—AR—Gene Expression—VDR—epilepsy syndrome	2.54e-05	0.000239	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT3—epilepsy syndrome	2.54e-05	0.000239	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EIF2AK2—epilepsy syndrome	2.51e-05	0.000236	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADAM10—epilepsy syndrome	2.48e-05	0.000233	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AQP1—epilepsy syndrome	2.47e-05	0.000232	CbGpPWpGaD
Drospirenone—AR—Gene Expression—H2AFX—epilepsy syndrome	2.41e-05	0.000226	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.37e-05	0.000223	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—S100B—epilepsy syndrome	2.34e-05	0.00022	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PPIA—epilepsy syndrome	2.32e-05	0.000218	CbGpPWpGaD
Drospirenone—AR—Gene Expression—YWHAZ—epilepsy syndrome	2.32e-05	0.000218	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.32e-05	0.000218	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SOCS3—epilepsy syndrome	2.32e-05	0.000218	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDC42—epilepsy syndrome	2.32e-05	0.000218	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP2D6—epilepsy syndrome	2.31e-05	0.000218	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NR3C1—epilepsy syndrome	2.29e-05	0.000215	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.26e-05	0.000212	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AVP—epilepsy syndrome	2.24e-05	0.000211	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CHRM3—epilepsy syndrome	2.24e-05	0.00021	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	2.24e-05	0.00021	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ADRA2A—epilepsy syndrome	2.2e-05	0.000207	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—POMC—epilepsy syndrome	2.2e-05	0.000207	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CCL2—epilepsy syndrome	2.15e-05	0.000202	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HES1—epilepsy syndrome	2.12e-05	0.000199	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SLC2A1—epilepsy syndrome	2.09e-05	0.000197	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.08e-05	0.000196	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PLCB1—epilepsy syndrome	2.07e-05	0.000195	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TH—epilepsy syndrome	2.06e-05	0.000194	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FYN—epilepsy syndrome	2.06e-05	0.000194	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—H2AFX—epilepsy syndrome	2.05e-05	0.000193	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MEF2C—epilepsy syndrome	2.05e-05	0.000193	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.04e-05	0.000192	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.03e-05	0.000191	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—YWHAZ—epilepsy syndrome	1.98e-05	0.000186	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NGF—epilepsy syndrome	1.96e-05	0.000184	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCR5—epilepsy syndrome	1.91e-05	0.000179	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HTR2A—epilepsy syndrome	1.87e-05	0.000175	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCG2—epilepsy syndrome	1.82e-05	0.000171	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	1.78e-05	0.000167	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TSC2—epilepsy syndrome	1.77e-05	0.000167	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AGT—epilepsy syndrome	1.77e-05	0.000166	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	1.77e-05	0.000166	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.75e-05	0.000165	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—APOE—epilepsy syndrome	1.73e-05	0.000163	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HMOX1—epilepsy syndrome	1.72e-05	0.000162	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SLC2A1—epilepsy syndrome	1.72e-05	0.000162	CbGpPWpGaD
Drospirenone—PTGS2—Disease—JUNB—epilepsy syndrome	1.71e-05	0.00016	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KDR—epilepsy syndrome	1.7e-05	0.00016	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CAT—epilepsy syndrome	1.7e-05	0.00016	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS1—epilepsy syndrome	1.7e-05	0.000159	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.68e-05	0.000158	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ABCB1—epilepsy syndrome	1.65e-05	0.000155	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PRKCB—epilepsy syndrome	1.64e-05	0.000154	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—IL6ST—epilepsy syndrome	1.63e-05	0.000153	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HBEGF—epilepsy syndrome	1.62e-05	0.000152	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.6e-05	0.00015	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	1.59e-05	0.00015	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT3—epilepsy syndrome	1.59e-05	0.000149	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ADAM10—epilepsy syndrome	1.55e-05	0.000146	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GPX1—epilepsy syndrome	1.54e-05	0.000144	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	1.52e-05	0.000143	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—BCHE—epilepsy syndrome	1.51e-05	0.000142	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—AKT1—epilepsy syndrome	1.51e-05	0.000142	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—POMC—epilepsy syndrome	1.49e-05	0.00014	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCL2—epilepsy syndrome	1.46e-05	0.000137	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDC42—epilepsy syndrome	1.45e-05	0.000136	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	1.44e-05	0.000135	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PLCB1—epilepsy syndrome	1.43e-05	0.000134	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TH—epilepsy syndrome	1.42e-05	0.000133	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AGT—epilepsy syndrome	1.35e-05	0.000127	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HES1—epilepsy syndrome	1.33e-05	0.000125	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—APOE—epilepsy syndrome	1.32e-05	0.000124	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FGF2—epilepsy syndrome	1.32e-05	0.000124	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FYN—epilepsy syndrome	1.29e-05	0.000121	CbGpPWpGaD
Drospirenone—PTGS2—Disease—H2AFX—epilepsy syndrome	1.29e-05	0.000121	CbGpPWpGaD
Drospirenone—PTGS2—Disease—YWHAZ—epilepsy syndrome	1.24e-05	0.000117	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—RELA—epilepsy syndrome	1.22e-05	0.000115	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MTOR—epilepsy syndrome	1.2e-05	0.000113	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CCR5—epilepsy syndrome	1.19e-05	0.000112	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HMOX1—epilepsy syndrome	1.19e-05	0.000111	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CAT—epilepsy syndrome	1.17e-05	0.00011	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCB1—epilepsy syndrome	1.14e-05	0.000107	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—POMC—epilepsy syndrome	1.13e-05	0.000107	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TSC2—epilepsy syndrome	1.11e-05	0.000104	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CASP3—epilepsy syndrome	1.1e-05	0.000104	CbGpPWpGaD
Drospirenone—PTGS2—Disease—APOE—epilepsy syndrome	1.09e-05	0.000102	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—JUN—epilepsy syndrome	1.07e-05	0.000101	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GPX1—epilepsy syndrome	1.06e-05	9.94e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MMP9—epilepsy syndrome	1.04e-05	9.8e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALB—epilepsy syndrome	1.03e-05	9.72e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—IL6ST—epilepsy syndrome	1.02e-05	9.58e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS2—epilepsy syndrome	1.01e-05	9.5e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SRC—epilepsy syndrome	9.61e-06	9.03e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—VEGFA—epilepsy syndrome	9.36e-06	8.8e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AGT—epilepsy syndrome	9.27e-06	8.71e-05	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—AKT1—epilepsy syndrome	9.19e-06	8.63e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—APOE—epilepsy syndrome	9.09e-06	8.54e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—epilepsy syndrome	9.05e-06	8.5e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FGF2—epilepsy syndrome	8.24e-06	7.75e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—POMC—epilepsy syndrome	7.81e-06	7.34e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MTOR—epilepsy syndrome	7.5e-06	7.05e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALB—epilepsy syndrome	7.12e-06	6.69e-05	CbGpPWpGaD
Drospirenone—AR—Gene Expression—AKT1—epilepsy syndrome	7e-06	6.58e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SRC—epilepsy syndrome	6.01e-06	5.65e-05	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKT1—epilepsy syndrome	5.97e-06	5.61e-05	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—AKT1—epilepsy syndrome	4.55e-06	4.27e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—AKT1—epilepsy syndrome	3.74e-06	3.51e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—AKT1—epilepsy syndrome	3.13e-06	2.94e-05	CbGpPWpGaD
